To learn more about this report, request sample copy
North America has dominated the global ambulatory infusion center market, and it is expected to account for 40.1% of the market share in 2024. The large size of the healthcare industry in the U.S. contributes significantly to the region's market share. Several leading pharmaceutical and medical device companies that offer infusion therapies have their headquarters in the U.S., driving easy accessibility and high adoption of these services. In addition, favorable reimbursement policies for outpatient infusion therapies encourage more patients to opt for ambulatory infusion centers rather than hospital-based treatment. This has further boosted the number of such centers across the region over time.
Asia Pacific is poised to be the fastest growing regional market during the forecast period. Rapid economic development and rising healthcare expenditures have improved access to sophisticated medical treatments in several Asia Pacific countries. China and India, in particular, represent major opportunities for players in this market. While in-hospital infusion services still account for the majority of the market in Asia Pacific, growing preference for convenience and cost-effectiveness is propelling the ambulatory infusion center segment. Established players from North America are also entering new markets in Asia Pacific through collaborations with local providers, supporting the regional market growth.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients